Skip to main content

Insights Archive

Coffee with CLEARSCRIPT: The PBM's Role in Mental Health Care

The PBMs Role in Mental Health Care

ClearScript’s VP of Clinical & Account Services, Nicole Christian and Lynn Branch, PBM Client Commitments Director, break down how PBMs are evolving to support mental health care. Learn how your plan can improve access, affordability, and outcomes.

Go to: The PBMs Role in Mental Health Care
AI generated podcast artwork of two men facing off

In Your Corner

From tackling specialty drug costs to delivering member-focused solutions, Kyle breaks down what it really means to have a PBM in your corner.

Go to: In Your Corner
Big PBM Markups: ClearScript shares and compares the latest FTC Reports

Big PBM Markups

What the FTC Reports Reveal—And Where ClearScript Stands The FTC’s interim reports on PBMs highlight a troubling trend: sky-high markups…

Go to: Big PBM Markups
Coffee with CLEARSCRIPT - Rx for Schools: How PBMs Help Districts Cut Costs & Stay Compliant

How PBMs Help Schools Cut Costs & Stay Compliant

In this episode of Coffee with ClearScript, we’ll unpack how PBMs can help school districts lower costs, ensure transparency, meet regulatory requirements, and support complex union-driven benefit designs.

Go to: How PBMs Help Schools Cut Costs & Stay Compliant
Ustekinumab bottle and syringe

Drug Spotlight: Yesintek and Selarsdi

YESINTEK (ustekinumab-kfce)Manufacturer: BioconLaunch Date: 2/24/2025 SELARSDI (ustekinumab-aekn)Manufacturer: Alvotech/TevaLaunch Date: 1/2025 YESINTEK & SELARSDI are biosimilars of reference product STELARA (Ustekinumab),…

Go to: Drug Spotlight: Yesintek and Selarsdi
Don't let your PBM off the hook!

Don’t let your PBM off the hook!

ClearScript experts Nicole Christian, PharmD, Vice President of Clinical Account Services, and Mackenzie Pfeiffer, Director of Account Management, and Vice President of Sale, Kyle D. Johnson, will share an inside look at the latest PBM challenges, including recent negative press, the rebate debate (including the role of international sourcing), the GLP-1 controversy, and the rise of biosimilars.

Go to: Don’t let your PBM off the hook!
An open bottle of generic pills

Drug Spotlight: Suzetrigine

suzetrigine (VX-548) Manufacturer: Vertex Approval Date: 1/30/2025 Suzetrigine possesses a novel mechanism of action as a voltage-gated sodium channel inactivator…

Go to: Drug Spotlight: Suzetrigine